Generics

Originals

Biosimilars

Medical devices

Nutraceuticals 8

Filters

Salmon oil manufacturers

8 products found

Filters

8 products found

salmon oil + vitamin e

Capsules 3000 mg + 40.2 mg

Country of origin
European Union
Recommended use
Immune system support
Product description
EPA and DHA (eicosapentaenoic acid and docosahexaenoic acid) contribute to normal heart function. The beneficial effect is obtained with a daily dose of 250 mg of EPA and DHA.
Manufacturer #26113

Manufacturer usually replies in 1 days

salmon oil + eicosapentaenoic acid + docosahexaenoic acid

Capsules 500 mg + 90 mg + 60 mg

Country of origin
European Union
GMP approvals
EU GMP
Recommended use
Heart and circulation
Product description
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) promotes a normal heart rate. The beneficial effect is obtained with a daily intake of EPA un DHA.
Manufacturer #24517

Manufacturer usually replies in nan days

salmon oil + eicosapentaenoic acid + docosahexaenoic acid

Capsules 500 mg + 90 mg + 60 mg

Country of origin
European Union
GMP approvals
EU GMP
Recommended use
Heart and circulation
Product description
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) promotes a normal heart rate. The beneficial effect is obtained with a daily intake of EPA un DHA.
Manufacturer #24517

Manufacturer usually replies in nan days

Want to see all 8 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation